Seizert Capital Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Seizert Capital Partners's DGX Position: Q1 2021 in Review
Seizert Capital Partners sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 105,543 shares — an estimated $12.6M sold.
Seizert Capital Partners first reported a position in DGX in Q1 2017 and held it in 16 quarters. The position peaked at $36.5M in Q4 2017. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2021.
- Seizert Capital Partners reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
- Seizert Capital Partners sold 105,543 Quest Diagnostics shares in Q1 2021, an estimated $12.6M.
- Seizert Capital Partners first reported a position in Quest Diagnostics in Q1 2017 and held it in 16 quarters.
- Seizert Capital Partners's Quest Diagnostics position peaked at $36.5M in Q4 2017.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.
Based on Seizert Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.